Mor­phoSys woos Mer­ck KGaA vet to lead late-stage push for block­buster prospect

Mor­phoSys made it clear when it shut­tered all US-based dis­cov­ery work ear­li­er this year that it wants to keep its re­search fo­cus in its home base of Ger­many. So it may be lit­tle sur­prise that as R&D chief Malte Pe­ters re­tires, his suc­ces­sor will be some­one who’s deeply en­meshed in the Eu­ro­pean bio­phar­ma scene.

Tim De­muth, a for­mer head of glob­al clin­i­cal de­vel­op­ment on­col­o­gy at Mer­ck KGaA who most re­cent­ly served as Pieris Phar­ma­ceu­ti­cals’ CMO, will be­come Mor­phoSys’ new chief re­search and de­vel­op­ment of­fi­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER